Name: Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment (en Inglés)
Price: 43430.00 CLP
Availability: InStock
Author: Miggiano, Riccardo ; Rizzi, Menico ; Ferraris, Davide M.
ISBN: 9783039366583

portada Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment (en Inglés)

Formato

Libro Físico

Editorial

Mdpi AG

Autor

Miggiano, Riccardo ; Rizzi, Menico ; Ferraris, Davide M.

Idioma

Inglés

N° páginas

128

Encuadernación

Tapa Dura

Dimensiones

24.4 x 17.0 x 1.3 cm

Peso

0.48 kg.

ISBN13

9783039366583

Categorías

Biología

Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment (en Inglés)

Miggiano, Riccardo ; Rizzi, Menico ; Ferraris, Davide M. (Autor) · Mdpi AG · Tapa Dura

Libro Físico

$ 43.430

$ 86.860

Ahorras: $ 43.430

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 08 de Julio y el Jueves 18 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment (en Inglés)"

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled "Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment" that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies.